Search PubMed⌕ Search

Biomedical subjects

C P De Vries

Publications and source records attributed to C P De Vries.

6 recordsLinked to original sources
PubMed1994

Dexamethasone increases and serum decreases growth hormone receptor binding to UMR-106.01 rat osteosarcoma cells.

Dexamethasone (DEX) is known to exert major effects on functions of osteoblast-like cells. We investigated its action on the regulation of GH receptors in the osteoblast-like osteosarcoma cells UMR-106.01. DEX stimulated [125I]human GH (hGH) binding to UMR-106.01 cells. This effect was dose dependent and significant in a concentration range of 10(-8)-10(-6) M. The maximum effect was an increase of 42 +/- 1.4% (n = 3; mean +/- SE) above control, P < 0.01, at 10(-7) M DEX. Time dependence of this stimulation was observed, with a peak between the 12th and the 16th h of incubation, an effect being still detectable at 48 h. Cycloheximide decreased [125I]hGH binding and completely abolished the stimulating effect of DEX, suggesting that modulation of [125I]hGH binding by DEX is fully dependent on protein synthesis. Addition of fetal calf serum (FCS) resulted in a dose-dependent decrease of [125I]hGH binding to 24 +/- 2% of control (n = 3; mean +/- SE), P < 0.001, without interfering with the stimulatory effect of DEX, the ratio of DEX vs. control being higher with increasing FCS doses. Taken together, these results suggest the existence of different pathways for the regulation of GH receptor binding to UMR-106.01 cells, including a stimulatory one at the pretranslational level for DEX and an inhibitory one for (growth) factors present in FCS.

Animals↗
PubMed1986

Sulphonylureas and biguanides do not affect insulin binding in H35 hepatoma cells.

Six sulphonylureas (tolbutamide, tolazamide, chlorpropamide, glibornuride, glipizide and gliquidone) and 2 biguanides (metformin and buformin) were tested for possible effects on insulin binding to H 35 rat hepatoma cells in culture. Insulin binding was measured after 24 and 72 hr of culturing cells in medium containing the drugs. Buformin and gliquidone were tested in concentrations from 10(-8)-5 X 10(-5) M, the other drugs in concentrations from 10(-7)-5 X 10(-4) M. All 24-hr experiments were repeated in cells down-regulated with 10 micrograms/ml insulin. None of the oral hypoglycemic agents tested had any significant influence on insulin binding to H 35 hepatoma cells, either in the presence or absence of insulin. We suggest that the insulin receptor status, at least in this type of liver cell, is not influenced by sulphonylureas or biguanides.

Animals↗
PubMedDate not supplied

Basal and LHRH-stimulated gonadotropin levels and the circadian rhythm of testosterone and the effect of exogenous testosterone thereon.

In seven eugonadal men, aged 20-26 years, a fall in plasma and saliva testosterone (T) levels between 8.00 and 16.00 h of the day was observed, but plasma oestradiol-17 beta levels did not show a significant variation. These findings substantiate the existence of a circadian rhythm in T levels. Concurrent with the decrease of T levels over the day, a small but significant rise in basal LH, but not in LHRH-stimulated LH levels were observed. Then the fall of plasma and saliva T levels over the day was prevented by the administration of 80 mg testosterone undecanoate (Andriol, Organon) by mouth at 8.00 h. A rise in plasma T and even more in saliva T levels was measured, which persisted till at least 16.00 h. At this hour basal LH, but not LHRH-stimulated LH levels appeared to be slightly, though significantly depressed. From our data we conclude that fluctuations of T levels of the magnitude of 25% around the baseline values, affect slightly basal LH levels, but not LHRH-stimulated LH levels.

Adult↗